Neuroendocrine prostate cancer (NEPC)
Clinical trials for Neuroendocrine prostate cancer (NEPC) explained in plain language.
Never miss a new study
Get alerted when new Neuroendocrine prostate cancer (NEPC) trials appear
Sign up with your email to follow new studies for Neuroendocrine prostate cancer (NEPC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug takes aim at hard-to-treat neuroendocrine prostate cancer
Disease control Not yet recruitingThis phase 2 trial tests a drug called sacituzumab tirumotecan in people with neuroendocrine prostate cancer, a rare and aggressive form that has progressed after platinum-based chemotherapy. The drug is given by IV infusion three times per 42-day cycle. The study measures how ma…
Matched conditions: NEUROENDOCRINE PROSTATE CANCER (NEPC)
Phase 2 • Sponsor: Virginia Commonwealth University • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Could a memory drug fight prostate cancer? small trial aims to find out
Disease control Not yet recruitingThis phase 2 trial tests whether memantine hydrochloride, a drug used for Alzheimer's, can help control advanced prostate cancer that has stopped responding to standard hormone therapy. Fifteen men with metastatic castration-resistant prostate cancer will take memantine alongside…
Matched conditions: NEUROENDOCRINE PROSTATE CANCER (NEPC)
Phase 2 • Sponsor: Bin Xu • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC